DZDinara Zholmukhamedova

Dinara Zholmukhamedova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dinara Zholmukhamedova has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Global Research Landscape of Determinants of Late-stage Breast Cancer Diagnosis: A Comprehensive Bibliometric Analysis

    by Dinara Zholmukhamedova, Maiya Taushanova, Anara Tulyaeva, Marzhan Aitmagambetova

    A BSTRACT: Background: Breast cancer remains the most commonly diagnosed malignancy among women worldwide, with late-stage diagnosis contributing significantly to increased mortality and poor prognosis. Understanding the research landscape and determinants associated with delayed diagnosis is essential for improving early detection strategies and reducing global disparities. Objective: This study aimed to conduct a comprehensive bibliometric analysis to evaluate global research trends, key contributors, collaboration patterns, and thematic structures related to determinants of late-stage breast cancer diagnosis. Materials and Methods: A descriptive bibliometric analysis was performed using data retrieved from the PubMed database. A structured search strategy combining Medical Subject Headings terms and keywords related to breast cancer, late-stage diagnosis, and associated determinants was applied. A total of 999 records were identified, of which 935 publications met the inclusion criteria and were included in the final analysis. Bibliometric analyses were conducted using the Bibliometrix package in R and VOSviewer to assess publication trends, citation impact, co-authorship networks, and conceptual structures. Results: The results demonstrated a substantial increase in publication output over time, particularly after 2010, indicating growing scientific interest in the field. Research productivity and citation impact were highly concentrated in high-income countries, with the United States and European nations leading global contributions. Collaboration networks revealed strong connections among developed regions, while low- and middle-income countries remained underrepresented. Thematic and conceptual analyses showed that the dataset was predominantly characterized by bibliometric and methodological research themes, with limited representation of clinically oriented topics such as diagnostic delay and healthcare access. Conclusion: This study highlights a growing but uneven research landscape in late-stage breast cancer diagnosis. Despite increasing scientific output, significant gaps remain in thematic focus and global representation. Future research should prioritize clinically relevant determinants, improve search strategies, and enhance contributions from underrepresented regions to better address disparities in breast cancer outcomes.

  • Open Access

    Prognostic significance of CD163 expression in colorectal cancer stroma: a retrospective cohort study

    by Nauryzbay Imanbayev, Yerbolat Iztleuov, Arip Koyshybaev, Aigul Zhumasheva, Beibit Baizakov, Nurgul Kereyeva, Zhanna Satenova, Aigerim Imanbayeva, Anara Tulyayeva, Dinara Zholmukhamedova, et al.

    Aim. Colorectal cancer (CRC) ranks among the leading causes of cancer-related mortality worldwide, with significant incidence and mortality rates recorded in Kazakhstan. CRC poses a substantial healthcare burden, prompting investigations into novel prognostic markers. Aim. This study investigates the prognostic significance of CD163 expression in patients with colorectal cancer. Methods. This retrospective cohort study was conducted in Aktobe, Kazakhstan, utilizing tissue microarrays from 175 patients diagnosed with Tumor, Node, Metastasis (TNM) stage I–IV colon adenocarcinoma. CD163 expression was assessed through immunohistochemistry. Kaplan-Meier survival analysis was employed to estimate 5-year overall survival, defined as the interval from diagnosis to death or last follow-up. Cox proportional hazards models were used to evaluate the relationship between CD163 expression levels and survival outcomes. Results. High CD163 expression was linked to advanced disease stage of colorectal cancer (p < 0.001), lymphovascular invasion (p < 0.001), perineural invasion (p < 0.001), and Collagen I>30%, A type (p<0.001). CD163 infiltration was a negative prognostic factor for colorectal cancer patients, with higher risks of death in the high CD163 expression group compared to the low CD163 group (HR=5.769, 95% CI 3.194 – 10.42, p<0.001). Conclusion. The findings highlight CD163 as a potential prognostic biomarker in CRC, warranting further investigation into its mechanistic role and therapeutic implications.

  • MYOEPITHELIAL CARCINOMA OF SOFT TISSUES OF THE RIGHT AXILLARY REGION WITH METASTASIS TO THE CECUM: A CLINICAL CASE

    by M. Aitmagambetova, A. Koishybaev, G. Smagulova, A. Zhumasheva, N. Kereeva, A. Tulyaeva, D. Koishybaeva, A. Zharylgapov, N. Imanbaev, G. Bakytzhanov, et al.

    Relevance: Myoepithelial carcinoma is a morphologically diverse tumor that arises either de novo or due to the malignant transformation of its benign counterpart, myoepithelium. These are relatively lesser-known lesions rarely found in the head and neck area. Myoepithelial carcinoma (MC) is a rare malignancy primarily found in the salivary gland. MK can be confused with many other tumors outside the salivary glands, as a wide range of cytomorphological and immunohistochemical features characterizes them. Soft tissue MCs are extremely rare, although a salivary gland MC is relatively common and well-known with similar morphology. The histogenesis of soft tissue MC is still unknown. The tumor may have myoepithelial differentiation but is not derived from myoepithelial cells. Due to the rarity of soft tissue MCs, the number of studies and data on this tumor’s clinical and pathological characteristics are limited. In addition, the limited number of diagnostic criteria and prognostic parameters makes diagnosing and treating soft tissue MC difficult. The article describes a rare case of MC, formed from the soft tissues of the axillary region, with metastasis to the cecum. The purpose was to describe the imaging and clinicopathological features of axillary myoepithelial carcinoma of soft tissues with metastasis to the cecum and to form an understanding of this disease. Methods: A rare case of soft tissue CM of the axillary region with metastasis to the cecum is described. A 57-year-old woman complained of lymphadenopathy in the right axillary region in October 2020. Results: According to ultrasound examination, the lymph node is up to 3.0x3.5 cm in the right axillary region. Based on histopathological and immunohistochemical (IHC) data, on 02/03/2022, the final diagnosis was made: MK of the soft tissues of the right axillary region. According to positron emission tomography/computed tomography (PET/CT), after 4 months, a local focus of active accumulation was detected in the projection of the cecum, with an adjacent enlarged regional lymph node of the paracolic group. On January 18, 2023, surgical treatment was performed in the following volume: “Right-sided hemicolectomy.” Histological examination confirmed MC. According to the multidisciplinary team’s (MDG) decision, the patient received 3 courses of targeted therapy. Conclusion: This case report raises awareness and improves MC diagnostics and treatment.